After-Hours Biotech Gainers: TNON, BIVI, EDSA, RNAZ, HCWBrttnews·Aug 18 at 09:00 PMRNAZ-3.37%HCWB+2.83%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Aug 18 at 04:06 PMIMCC-1.14%AHG-8.85%
HCW Biologics Inc. Q2 2026: Revenue $135.6K, EPS $(11.58) — 10-Q SummaryTradingView·Aug 14 at 02:41 PMHCWB+2.83%
HCWB: Positive clinical data, higher licensing revenue, and new equity funding offset by net loss and funding risksQuartr·Aug 14 at 02:24 PMHCWB+2.83%
HCW Biologics Q2 FY26 net loss widens to $5.2 million; revenue rises to $135,568PUBT·Aug 14 at 02:15 PMHCWB+2.83%
HCW Biologics restates Q1 EPS, cutting net income attributable to common shareholders by USD 728,000PUBT·Aug 14 at 02:12 PMHCWB+2.83%
HCW Biologics says Q1 2026 financials cannot be relied on due to EPS misstatementPUBT·Aug 14 at 02:01 PMHCWB+2.83%
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results | HCWB Stock NewsStockTitan·Aug 14 at 06:15 AMHCWB+2.83%
HCW Biologics director Scott T. Garrett acquires 7,736 common shares for $19,995.56PUBT·Jul 31 at 03:02 PMHCWB+2.83%
HCW Biologics issues 400,000 pre-funded warrants in $1.6 million private placementPUBT·Jul 29 at 08:06 AMHCWB+2.83%
